Cargando…

Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China

BACKGROUND: Recently, the paraneoplastic neurologic syndrome (PNS) diagnostic criteria have received a major update with a new score system over the past 16 years. We aimed to evaluate the diagnostic performance and clinical utility in China. METHODS: An eligible cohort of 113 Chinese patients diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Meng-Ting, Qiao, Song, Lai, Qi-Lun, Zheng, Yang, Yang, Fan, Fang, Gao-Li, Shen, Chun-Hong, Zhang, Yin-Xi, Ding, Mei-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841409/ https://www.ncbi.nlm.nih.gov/pubmed/35173717 http://dx.doi.org/10.3389/fimmu.2022.790400

Ejemplares similares

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
por: Guo, Yi, et al.
Publicado: (2021)

Brain lesion distribution criteria distinguish demyelinating diseases in China
por: Cai, Meng‐Ting, et al.
Publicado: (2019)

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis
por: Zheng, Yang, et al.
Publicado: (2020)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
por: Arnaldos-Pérez, Cristina, et al.
Publicado: (2023)

Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review
por: Zhang, Tian-Yi, et al.
Publicado: (2021)

Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
por: Rezk, Mohamed, et al.
Publicado: (2023)

Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa
por: Kim, Jong Hoon, et al.
Publicado: (2019)

Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome
por: Mahta, Ali, et al.
Publicado: (2012)

Paraneoplastic neurological syndromes
por: Honnorat, Jérôme, et al.
Publicado: (2007)

Paraneoplastic Neurological Disorders
por: Newsom-Davis, John
Publicado: (1999)

Paraneoplastic Neurologic Disorders
por: Gilligan, Michael, et al.
Publicado: (2023)

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
por: Déchelotte, Benoît, et al.
Publicado: (2020)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
por: Ruiz-García, Raquel, et al.
Publicado: (2019)

Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria
por: Zoccarato, Marco, et al.
Publicado: (2021)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Diagnostic Dilemma of Paraneoplastic Rheumatic Disorders: Case Series and Narrative Review
por: Cho, Youngmin, et al.
Publicado: (2021)

Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia
por: Vial, Guillaume, et al.
Publicado: (2019)

Paraneoplastic neurological complications of breast cancer
por: Fanous, Ibrahim, et al.
Publicado: (2016)

The Pursuit of Precision in Paraneoplastic Neurologic Disease
por: Abbatemarco, Justin R., et al.
Publicado: (2021)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
por: Chiu, Daniel, et al.
Publicado: (2023)

Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review
por: Li, Lin, et al.
Publicado: (2022)

Update on Paraneoplastic Cerebellar Degeneration
por: Loehrer, Philipp Alexander, et al.
Publicado: (2021)

Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorder
por: Ameratunga, Rohan, et al.
Publicado: (2014)

Improved diagnostic performance of CASPAR criteria with integration of ultrasound
por: Geng, Yan, et al.
Publicado: (2022)

Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome
por: Zheng*, Yang, et al.
Publicado: (2020)

Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications
por: Yshii, Lidia, et al.
Publicado: (2020)

Paraneoplastic neurologic syndrome: A practical approach
por: Kannoth, Sudheeran
Publicado: (2012)

Paraneoplastic neurological syndromes associated with ovarian tumors
por: Zaborowski, Mikolaj Piotr, et al.
Publicado: (2014)

Paraneoplastic neurological syndromes: clinical presentations and management
por: Devine, Michelle F., et al.
Publicado: (2021)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
por: Lin, Jingfang, et al.
Publicado: (2022)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Enlarged perivascular spaces, neuroinflammation and neurological dysfunction in NMOSD patients
por: Yao, Xiao-Ying, et al.
Publicado: (2022)

Paraneoplastic cutaneous manifestations: concepts and updates()
por: da Silva, Josenilson Antônio, et al.
Publicado: (2013)

Cell-Mediated Immune Responses in Paraneoplastic Neurological Syndromes
por: Zaborowski, Mikolaj Piotr, et al.
Publicado: (2013)

Breast Cancer Presents with a Paraneoplastic Neurologic Syndrome
por: Barata, Pedro Coelho, et al.
Publicado: (2012)

Paraneoplastic Neurologic Syndromes in Children: A Review Article
por: ALAVI, Samin
Publicado: (2013)

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017)

Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome
por: Sun, Xuan, et al.
Publicado: (2020)

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7gljgbfs59ndsk31jivk63jd52